Chengyi pharmaceutical industry focuses on new product development and technological innovation, and has established long-term technical cooperation with dozens of domestic first-class research institutes and universities. The company has dozens of experts advisory group for research, development and technology in different categories of pharmaceutical ingredients, preparations, APIs and pharmaceutical intermediates.
Chengyi pharmaceutical industry also has its own r & d department, three research institutes and two GMP - compliant pilot plants, and has established the Department of medicine, pharmacy experts from the domestic senior leadership, responsible for the development of new drugs and other related work report.
In recent years, Zhejiang Chengyi pharmaceutical co.,ltd. has developed ribavirin, acyclovir pharmaceutical, azathioprine, clindamycin, erythromycin stinoprat, N-acetylcysteine, torasemide and glucosamine hydrochloride and many other high-tech products. It also formed the mass production from raw materials to injections and capsules of series products of the same variety, and achieved good economic benefits.
● 6 production workshops meeting GMP standards
● 2 preparation workshops
● 1 pilot plant
● 105 50L to 10000L glass lined and stainless steel reaction kettle
● Total response capacity: 260 M3
● [reaction temperature: -90 DEG C to 180 DEG C
● Pressure range: -0.1Mpa - 8 MPa
● Clean area: 10 (level 100000)